跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 78,126 条关于
“BCL-2 inhibitors”
全部
78,126
临床试验
49,869
药物
10,696
机构
1,415
资讯
16,146
去年
Acalabrutinib Plus Venetoclax Significantly Improves PFS in Untreated CLL
去年
Ascentage Pharma's Lisaftoclax Receives Priority Review in China for Relapsed/Refractory CLL/SLL
去年
China's NMPA Accepts Ascentage Pharma's NDA for Lisaftoclax in R/R CLL/SLL with Priority Review
去年
Evolving Strategies in CLL: Rethinking Continuous BTK Inhibitor Therapy
去年
Mantle Cell Lymphoma Pipeline Shows Promise with Novel Targeted Therapies
去年
Lomond Therapeutics' Lonitoclax Shows Promising Safety Profile in Phase 1 Trial
去年
InnoCare's Mesutoclax Receives Breakthrough Therapy Designation in China for Lymphoma Treatment
9个月前
Novel BTK Degrader BGB-16673 Demonstrates 85% Response Rate in Heavily Pretreated CLL/SLL Patients
去年
Aumolertinib Shows Promise in NSCLC, Ivonescimab Outperforms Pembrolizumab, and Novel Therapies Emerge in Breast Cancer and Multiple Myeloma
9个月前
AbbVie Presents Breakthrough Data at ASH 2025 Demonstrating Significant Advances in Blood Cancer Treatment
第 1 页,共 1615 页
上一页
下一页